Danske Bank A/S Royalty Pharma PLC Transaction History

Danske Bank A/S

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 19, 2025	BUY	$34.9 - $37.91 $16.9 Million - $18.4 Million	485,665 New	485,665 $17.1 Million
Q2 2025 Dec 18, 2025	BUY	$30.85 - $36.14 $1.68 Million - $1.97 Million	54,547 Added 16.42%	386,665 $13.9 Million
Q1 2025 Dec 18, 2025	SELL	$25.75 - $33.86 $3.95 Million - $5.2 Million	-153,547 Reduced 31.62%	332,118 $10.3 Million

535

303M

1.34M

252K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $17.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

Stay updated on Danske Bank A/S with notifications on news.